Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients

By Zoe Edwards, Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
Jonathan Silcock, Associate Professor in Pharmacy Practice, University of Bradford
Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.

Under Nice’s…

Read complete article

~	Fears grow that Lebanon may become another Gaza

~	‘No antidote for bad polls’: Recalling the New York Times’ 1956 election experiment in shoe-leather reporting

~	Can Montana’s ‘last rural Democrat’ survive another election?

~	Is it COVID-19? Flu? At-home rapid tests could help you and your doctor decide on a treatment plan

~	How foreign operations are manipulating social media to influence your views

~	Trump and Harris are sharply divided on science, but share common ground on US technology policy

~	Six ways to holiday like an old-school travel journalist – without using the internet

~	UN extends Kenyan policing mission in Haiti in futile attempt to tackle gangs

~	Turkey’s plan to recycle more has made life hard for its informal waste pickers

~	How discovering the power of allusion enabled me to write better rap music